Oncoimmune Inc

Acquired

Rockville, United States · Founded 2017 · $61.7M raised

Employees
1–10
Founded
2017
Total Funding
$61.7M
Last Round
GrantSep 2020
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

OncoImmune was a privately-held, clinical-stage biopharmaceutical company based in Rockville, Maryland. Merck (NYSE: MRK) entered into a definitive agreement to acquire all outstanding shares of OncoImmune for an upfront payment of $425 million in cash, an acquisition that added to Merck's suite of clinical programs in response to COVID-19. Merck said it would accelerate development of CD24Fc, OncoImmune's candidate for the treatment of patients with severe and critical COVID-19.

Summary

Oncoimmune Inc is a Biotech company based in Rockville, United States, founded in 2017. It has raised $61.7M in total across 6 rounds, most recently a Grant round in Sep 2020. Investors include National Institutes of Health, 3E Bioventures Capital and Kaitai Capital.

Funding History

Series BSeries BSep 2020
$56.0M

Sign up to see all 6 events

Funding: Grant through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Oncoimmune Inc on Indexed.vc
<a href="https://indexed.vc/companies/oncoimmune-inc"><img src="https://indexed.vc/api/badge/company/oncoimmune-inc" alt="Oncoimmune Inc on Indexed.vc" width="260" height="76" /></a>